TESAMORELIN 10MG

Tesamorelin

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that is primarily studied for its ability to stimulate the release of endogenous growth hormone (GH) from the pituitary gland. It has been investigated for its effects on body composition, fat metabolism, and metabolic function, particularly in individuals with conditions such as HIV-associated lipodystrophy.

Overview

Tesamorelin is a 44-amino-acid peptide that functions as a growth hormone secretagogue. By stimulating the pituitary gland, it can increase pulsatile secretion of growth hormone, which in turn may support protein synthesis, lipid metabolism, and overall endocrine regulation.

• Stimulates endogenous growth hormone release
• Potentially reduces visceral adipose tissue
• May support lean body mass and metabolic regulation
• Studied primarily in clinical populations with fat redistribution disorders

Specifications

• Peptide Length: 44 amino acids
• Molecular Formula: C203H340N56O60
• Molecular Weight: 4884.84 g/mol
• Other Names: Tesamorelin Acetate, Egrifta

Research and Clinical Studies

Body Composition and Fat Reduction

Clinical studies have shown that Tesamorelin may help reduce visceral adipose tissue in patients with HIV-associated lipodystrophy. Regular administration of the peptide has been linked to decreased abdominal fat accumulation without significant loss of lean body mass.

Metabolic Effects

Tesamorelin may contribute to improvements in lipid metabolism, including reductions in triglycerides and enhancement of insulin sensitivity. Some studies suggest potential benefits for cardiovascular risk factors associated with central fat accumulation.

Mechanism of Action

Tesamorelin acts by binding to receptors in the pituitary gland, stimulating growth hormone secretion. This leads to downstream effects, including increased insulin-like growth factor 1 (IGF-1) production, which mediates many of the peptide’s metabolic and anabolic effects.

Usage Considerations

Tesamorelin is primarily used in research and clinical settings. Its administration is generally by subcutaneous injection. Dosage, frequency, and monitoring should follow established research protocols or clinical guidelines.

Note: Tesamorelin peptide is intended for research and laboratory use only. Please review and adhere to all applicable Terms and Conditions before ordering.